Literature DB >> 10359610

The human G2 checkpoint control protein hRAD9 is a nuclear phosphoprotein that forms complexes with hRAD1 and hHUS1.

R P St Onge1, C M Udell, R Casselman, S Davey.   

Abstract

Eukaryotic cells actively block entry into mitosis in the presence of DNA damage or incompletely replicated DNA. This response is mediated by signal transduction cascades called cell cycle checkpoints. We show here that the human checkpoint control protein hRAD9 physically associates with two other checkpoint control proteins, hRAD1 and hHUS1. Furthermore, hRAD1 and hHUS1 themselves interact, analogously to their fission yeast homologues Rad1 and Hus1. We also show that hRAD9 is present in multiple phosphorylation forms in vivo. These phosphorylated forms are present in tissue culture cells that have not been exposed to exogenous sources of DNA damage, but it remains possible that endogenous damage or naturally occurring replication intermediates cause the observed phosphorylation. Finally, we show that hRAD9 is a nuclear protein, indicating that in this signal transduction pathway, hRAD9 is physically proximal to the upstream (DNA damage) signal rather than to the downstream, cytoplasmic, cell cycle machinery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10359610      PMCID: PMC25401          DOI: 10.1091/mbc.10.6.1985

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  51 in total

1.  Multiple mutations in human cancers.

Authors:  L A Loeb; F C Christians
Journal:  Mutat Res       Date:  1996-02-19       Impact factor: 2.433

2.  The novel DNA damage checkpoint protein ddc1p is phosphorylated periodically during the cell cycle and in response to DNA damage in budding yeast.

Authors:  M P Longhese; V Paciotti; R Fraschini; R Zaccarini; P Plevani; G Lucchini
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

3.  Hus1p, a conserved fission yeast checkpoint protein, interacts with Rad1p and is phosphorylated in response to DNA damage.

Authors:  C F Kostrub; K Knudsen; S Subramani; T Enoch
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

Review 4.  Cancer of the microsatellite mutator phenotype.

Authors:  M Perucho
Journal:  Biol Chem       Date:  1996-11       Impact factor: 3.915

5.  The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species.

Authors:  K Savitsky; S Sfez; D A Tagle; Y Ziv; A Sartiel; F S Collins; Y Shiloh; G Rotman
Journal:  Hum Mol Genet       Date:  1995-11       Impact factor: 6.150

6.  S-phase-specific activation of Cds1 kinase defines a subpathway of the checkpoint response in Schizosaccharomyces pombe.

Authors:  H D Lindsay; D J Griffiths; R J Edwards; P U Christensen; J M Murray; F Osman; N Walworth; A M Carr
Journal:  Genes Dev       Date:  1998-02-01       Impact factor: 11.361

7.  A human homolog of the Schizosaccharomyces pombe rad9+ checkpoint control gene.

Authors:  H B Lieberman; K M Hopkins; M Nass; D Demetrick; S Davey
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

8.  Mutations of mitotic checkpoint genes in human cancers.

Authors:  D P Cahill; C Lengauer; J Yu; G J Riggins; J K Willson; S D Markowitz; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

9.  Dual roles of ATM in the cellular response to radiation and in cell growth control.

Authors:  Y Xu; D Baltimore
Journal:  Genes Dev       Date:  1996-10-01       Impact factor: 11.361

10.  cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein.

Authors:  K A Cimprich; T B Shin; C T Keith; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

View more
  39 in total

1.  Characterization of Schizosaccharomyces pombe Hus1: a PCNA-related protein that associates with Rad1 and Rad9.

Authors:  T Caspari; M Dahlen; G Kanter-Smoler; H D Lindsay; K Hofmann; K Papadimitriou; P Sunnerhagen; A M Carr
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  Structure-based predictions of Rad1, Rad9, Hus1 and Rad17 participation in sliding clamp and clamp-loading complexes.

Authors:  C Venclovas; M P Thelen
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

3.  Regulation of ATR substrate selection by Rad17-dependent loading of Rad9 complexes onto chromatin.

Authors:  Lee Zou; David Cortez; Stephen J Elledge
Journal:  Genes Dev       Date:  2002-01-15       Impact factor: 11.361

4.  Structure-function analysis of fission yeast Hus1-Rad1-Rad9 checkpoint complex.

Authors:  R Kaur; C F Kostrub; T Enoch
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

5.  Purification and characterization of human DNA damage checkpoint Rad complexes.

Authors:  L A Lindsey-Boltz; V P Bermudez; J Hurwitz; A Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

6.  Preferential binding of ATR protein to UV-damaged DNA.

Authors:  Keziban Unsal-Kaçmaz; Alexander M Makhov; Jack D Griffith; Aziz Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

Review 7.  The role of RAD9 in tumorigenesis.

Authors:  Howard B Lieberman; Joshua D Bernstock; Constantinos G Broustas; Kevin M Hopkins; Corinne Leloup; Aiping Zhu
Journal:  J Mol Cell Biol       Date:  2011-02       Impact factor: 6.216

Review 8.  Control of the G2/M transition.

Authors:  George R Stark; William R Taylor
Journal:  Mol Biotechnol       Date:  2006-03       Impact factor: 2.695

9.  Molecular modeling-based analysis of interactions in the RFC-dependent clamp-loading process.

Authors:  Ceslovas Venclovas; Michael E Colvin; Michael P Thelen
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

10.  Interaction of apurinic/apyrimidinic endonuclease 2 (Apn2) with Myh1 DNA glycosylase in fission yeast.

Authors:  Jin Jin; Bor-Jang Hwang; Po-Wen Chang; Eric A Toth; A-Lien Lu
Journal:  DNA Repair (Amst)       Date:  2014-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.